Atypical hemolytic uremic syndrome. 1995

S Kavukçu, and G Irken, and N Olgun, and A Güçlü
Department of Pediatrics, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey.

The pathogenesis of atypical uremic syndrome (HUS), which is rarely encountered in childhood, is poorly understood and its mortality and morbidity rates are high. A wide variety of therapeutic approaches has been attempted and the literature contains numerous conflicting reports about the results of these approaches. In a case diagnosed as recurrent atypical HUS, pulse methyl prednisolone, fresh frozen plasma infusions and plasma exchange transfusion were used at different stages of the disease with satisfactory response.

UI MeSH Term Description Entries
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Kavukçu, and G Irken, and N Olgun, and A Güçlü
November 2015, Medicina clinica,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
September 2011, Orphanet journal of rare diseases,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
June 2018, Pediatric clinics of North America,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
November 2013, Seminars in nephrology,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
September 2010, Current opinion in hematology,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
December 2016, Hematology. American Society of Hematology. Education Program,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
October 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
June 2018, Revista medica de Chile,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
February 2002, Indian pediatrics,
S Kavukçu, and G Irken, and N Olgun, and A Güçlü
August 2014, Advances in pediatrics,
Copied contents to your clipboard!